Logo image of IAS

INTEGRAL AD SCIENCE HOLDING (IAS) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:IAS - US45828L1089 - Common Stock

10.34 USD
+0.08 (+0.78%)
Last: 12/22/2025, 8:00:02 PM
10.33 USD
-0.01 (-0.1%)
After Hours: 12/22/2025, 8:00:02 PM
Fundamental Rating

6

Taking everything into account, IAS scores 6 out of 10 in our fundamental rating. IAS was compared to 95 industry peers in the Media industry. IAS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. IAS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year IAS was profitable.
IAS had a positive operating cash flow in the past year.
In multiple years IAS reported negative net income over the last 5 years.
IAS had a positive operating cash flow in each of the past 5 years.
IAS Yearly Net Income VS EBIT VS OCF VS FCFIAS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

IAS has a better Return On Assets (3.87%) than 74.74% of its industry peers.
IAS has a Return On Equity of 4.23%. This is in the better half of the industry: IAS outperforms 69.47% of its industry peers.
IAS's Return On Invested Capital of 3.81% is in line compared to the rest of the industry. IAS outperforms 57.89% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IAS is below the industry average of 7.09%.
The 3 year average ROIC (2.15%) for IAS is below the current ROIC(3.81%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.87%
ROE 4.23%
ROIC 3.81%
ROA(3y)1.74%
ROA(5y)-0.65%
ROE(3y)2.15%
ROE(5y)-1.58%
ROIC(3y)2.15%
ROIC(5y)N/A
IAS Yearly ROA, ROE, ROICIAS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -5 -10

1.3 Margins

With a decent Profit Margin value of 7.91%, IAS is doing good in the industry, outperforming 76.84% of the companies in the same industry.
The Operating Margin of IAS (10.67%) is better than 64.21% of its industry peers.
IAS has a better Gross Margin (77.42%) than 91.58% of its industry peers.
In the last couple of years the Gross Margin of IAS has remained more or less at the same level.
Industry RankSector Rank
OM 10.67%
PM (TTM) 7.91%
GM 77.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.89%
GM growth 5Y-1.46%
IAS Yearly Profit, Operating, Gross MarginsIAS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

8

2. Health

2.1 Basic Checks

IAS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, IAS has more shares outstanding
Compared to 5 years ago, IAS has more shares outstanding
IAS has a better debt/assets ratio than last year.
IAS Yearly Shares OutstandingIAS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
IAS Yearly Total Debt VS Total AssetsIAS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

IAS has an Altman-Z score of 11.12. This indicates that IAS is financially healthy and has little risk of bankruptcy at the moment.
IAS's Altman-Z score of 11.12 is amongst the best of the industry. IAS outperforms 94.74% of its industry peers.
There is no outstanding debt for IAS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.12
ROIC/WACC0.45
WACC8.51%
IAS Yearly LT Debt VS Equity VS FCFIAS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 4.43 indicates that IAS has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.43, IAS belongs to the best of the industry, outperforming 97.89% of the companies in the same industry.
A Quick Ratio of 4.43 indicates that IAS has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.43, IAS belongs to the top of the industry, outperforming 97.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.43
Quick Ratio 4.43
IAS Yearly Current Assets VS Current LiabilitesIAS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 60.00% over the past year.
Looking at the last year, IAS shows a quite strong growth in Revenue. The Revenue has grown by 15.51% in the last year.
The Revenue has been growing by 19.95% on average over the past years. This is quite good.
EPS 1Y (TTM)60%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
Revenue 1Y (TTM)15.51%
Revenue growth 3Y17.89%
Revenue growth 5Y19.95%
Sales Q2Q%15.6%

3.2 Future

The Earnings Per Share is expected to grow by 33.57% on average over the next years. This is a very strong growth
IAS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.02% yearly.
EPS Next Y50.23%
EPS Next 2Y29.89%
EPS Next 3Y33.57%
EPS Next 5YN/A
Revenue Next Year14.78%
Revenue Next 2Y13.09%
Revenue Next 3Y12.73%
Revenue Next 5Y12.02%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
IAS Yearly Revenue VS EstimatesIAS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M 1B
IAS Yearly EPS VS EstimatesIAS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

IAS is valuated quite expensively with a Price/Earnings ratio of 32.31.
62.11% of the companies in the same industry are more expensive than IAS, based on the Price/Earnings ratio.
IAS is valuated rather expensively when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 26.65 indicates a quite expensive valuation of IAS.
IAS's Price/Forward Earnings ratio is in line with the industry average.
IAS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 32.31
Fwd PE 26.65
IAS Price Earnings VS Forward Price EarningsIAS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as IAS.
IAS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IAS is cheaper than 66.32% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.93
EV/EBITDA 12.21
IAS Per share dataIAS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

IAS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IAS has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as IAS's earnings are expected to grow with 33.57% in the coming years.
PEG (NY)0.64
PEG (5Y)N/A
EPS Next 2Y29.89%
EPS Next 3Y33.57%

0

5. Dividend

5.1 Amount

No dividends for IAS!.
Industry RankSector Rank
Dividend Yield 0%

INTEGRAL AD SCIENCE HOLDING

NASDAQ:IAS (12/22/2025, 8:00:02 PM)

After market: 10.33 -0.01 (-0.1%)

10.34

+0.08 (+0.78%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-04 2025-11-04/bmo
Earnings (Next)02-26 2026-02-26/amc
Inst Owners58.76%
Inst Owner Change1.33%
Ins Owners0.84%
Ins Owner Change-46.84%
Market Cap1.74B
Revenue(TTM)590.67M
Net Income(TTM)46.72M
Analysts54
Price Target11.71 (13.25%)
Short Float %6.4%
Short Ratio4.39
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)82.04%
Min EPS beat(2)11.7%
Max EPS beat(2)152.38%
EPS beat(4)3
Avg EPS beat(4)56.58%
Min EPS beat(4)-16.56%
Max EPS beat(4)152.38%
EPS beat(8)6
Avg EPS beat(8)49.12%
EPS beat(12)9
Avg EPS beat(12)-102.02%
EPS beat(16)11
Avg EPS beat(16)-73.47%
Revenue beat(2)2
Avg Revenue beat(2)2.78%
Min Revenue beat(2)2.42%
Max Revenue beat(2)3.15%
Revenue beat(4)4
Avg Revenue beat(4)2.55%
Min Revenue beat(4)1.81%
Max Revenue beat(4)3.15%
Revenue beat(8)7
Avg Revenue beat(8)1.18%
Revenue beat(12)11
Avg Revenue beat(12)1.79%
Revenue beat(16)15
Avg Revenue beat(16)2.09%
PT rev (1m)0%
PT rev (3m)-11.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.4%
EPS NY rev (1m)-1.2%
EPS NY rev (3m)-0.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.22%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)0.19%
Valuation
Industry RankSector Rank
PE 32.31
Fwd PE 26.65
P/S 2.94
P/FCF 12.93
P/OCF 9.79
P/B 1.57
P/tB 6.94
EV/EBITDA 12.21
EPS(TTM)0.32
EY3.09%
EPS(NY)0.39
Fwd EY3.75%
FCF(TTM)0.8
FCFY7.73%
OCF(TTM)1.06
OCFY10.22%
SpS3.52
BVpS6.58
TBVpS1.49
PEG (NY)0.64
PEG (5Y)N/A
Graham Number6.88
Profitability
Industry RankSector Rank
ROA 3.87%
ROE 4.23%
ROCE 5.55%
ROIC 3.81%
ROICexc 4.3%
ROICexgc 28.48%
OM 10.67%
PM (TTM) 7.91%
GM 77.42%
FCFM 22.72%
ROA(3y)1.74%
ROA(5y)-0.65%
ROE(3y)2.15%
ROE(5y)-1.58%
ROIC(3y)2.15%
ROIC(5y)N/A
ROICexc(3y)2.35%
ROICexc(5y)N/A
ROICexgc(3y)21.82%
ROICexgc(5y)N/A
ROCE(3y)3.13%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.89%
GM growth 5Y-1.46%
F-Score7
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 62.98%
Cap/Sales 7.31%
Interest Coverage 250
Cash Conversion 134.81%
Profit Quality 287.27%
Current Ratio 4.43
Quick Ratio 4.43
Altman-Z 11.12
F-Score7
WACC8.51%
ROIC/WACC0.45
Cap/Depr(3y)52.63%
Cap/Depr(5y)38.91%
Cap/Sales(3y)6.28%
Cap/Sales(5y)5.42%
Profit Quality(3y)639.69%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)60%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20%
EPS Next Y50.23%
EPS Next 2Y29.89%
EPS Next 3Y33.57%
EPS Next 5YN/A
Revenue 1Y (TTM)15.51%
Revenue growth 3Y17.89%
Revenue growth 5Y19.95%
Sales Q2Q%15.6%
Revenue Next Year14.78%
Revenue Next 2Y13.09%
Revenue Next 3Y12.73%
Revenue Next 5Y12.02%
EBIT growth 1Y25.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year255.99%
EBIT Next 3Y65.94%
EBIT Next 5Y41.75%
FCF growth 1Y98.17%
FCF growth 3Y15.7%
FCF growth 5YN/A
OCF growth 1Y79.1%
OCF growth 3Y22.84%
OCF growth 5YN/A

INTEGRAL AD SCIENCE HOLDING / IAS FAQ

Can you provide the ChartMill fundamental rating for INTEGRAL AD SCIENCE HOLDING?

ChartMill assigns a fundamental rating of 6 / 10 to IAS.


What is the valuation status for IAS stock?

ChartMill assigns a valuation rating of 5 / 10 to INTEGRAL AD SCIENCE HOLDING (IAS). This can be considered as Fairly Valued.


Can you provide the profitability details for INTEGRAL AD SCIENCE HOLDING?

INTEGRAL AD SCIENCE HOLDING (IAS) has a profitability rating of 6 / 10.


Can you provide the financial health for IAS stock?

The financial health rating of INTEGRAL AD SCIENCE HOLDING (IAS) is 8 / 10.


What is the expected EPS growth for INTEGRAL AD SCIENCE HOLDING (IAS) stock?

The Earnings per Share (EPS) of INTEGRAL AD SCIENCE HOLDING (IAS) is expected to grow by 50.23% in the next year.